Job Search Results - Biospace
Get Our FREE Industry eNewsletter


Refine Job Search:

Clear All Selections
Selected Employer
AbbVie Stemcentrx
Location (12)
Employers (12)
Area of Expertise (0)
Posted Date (12)
Position Type (12)
Required Education (12)

Clear All Selections

Your search returned 12 jobs



6/28/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/28/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/27/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/23/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/23/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/23/2017
AbbVie Stemcentrx
South San Francisco, CA

Position Description:Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being...

6/20/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/20/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/20/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta™, and Empliciti™ — and a pipeline containing multiple promising new molecules that are being studied...

6/20/2017
AbbVie Stemcentrx
San Francisco, CA

Oncology is a keytherapeutic area for AbbVie, with a portfolio consisting of three marketedproducts — Imbruvica, Venclexta, and Empliciti — and a pipeline containingmultiple promising new molecules that are being studied in nearly 200...